Literature DB >> 18468486

Vascular endothelial growth factor of the lung: friend or foe.

Rubin M Tuder1, Jeong H Yun.   

Abstract

The discovery of vascular endothelial growth factor (VEGF) changed the field of angiogenesis. We have learned that VEGF has broader actions than merely a driver of tumor angiogenesis, particularly that VEGF controlled several fundamental functions and properties of endothelial cells and nonendothelial cells. The lung is one of the main organs where VEGF controls several crucial physiological functions. These actions rely on tightly regulated temporal and concentration gradients of VEGF and VEGF receptor expression in the lung. Excessive or diminished VEGF have been linked to abnormal lung phenotypes and, in humans, linked to several diseases. The beneficial and detrimental actions of VEGF underscore that therapeutic targeting of VEGF in disease has to carefully consider the lung biology of VEGF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18468486      PMCID: PMC2622735          DOI: 10.1016/j.coph.2008.03.003

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  58 in total

1.  Reciprocal relation between VEGF and NO in the regulation of endothelial integrity.

Authors:  Y Tsurumi; T Murohara; K Krasinski; D Chen; B Witzenbichler; M Kearney; T Couffinhal; J M Isner
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

Review 2.  Stem cells in lung development, disease, and therapy.

Authors:  R J Mason; M C Williams; H L Moses; S Mohla; M A Berberich
Journal:  Am J Respir Cell Mol Biol       Date:  1997-04       Impact factor: 6.914

3.  VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo.

Authors:  X Zeng; S E Wert; R Federici; K G Peters; J A Whitsett
Journal:  Dev Dyn       Date:  1998-03       Impact factor: 3.780

4.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

5.  Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension.

Authors:  C Partovian; S Adnot; S Eddahibi; E Teiger; M Levame; P Dreyfus; B Raffestin; C Frelin
Journal:  Am J Physiol       Date:  1998-12

6.  Vascular endothelial growth factor gene expression in human fetal lung in vitro.

Authors:  M J Acarregui; S T Penisten; K L Goss; K Ramirez; J M Snyder
Journal:  Am J Respir Cell Mol Biol       Date:  1999-01       Impact factor: 6.914

Review 7.  Primary pulmonary hypertension between inflammation and cancer.

Authors:  N F Voelkel; C Cool; S D Lee; L Wright; M W Geraci; R M Tuder
Journal:  Chest       Date:  1998-09       Impact factor: 9.410

8.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.

Authors:  B Barleon; S Sozzani; D Zhou; H A Weich; A Mantovani; D Marmé
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

9.  The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency.

Authors:  B A Keyt; L T Berleau; H V Nguyen; H Chen; H Heinsohn; R Vandlen; N Ferrara
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

10.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity.

Authors:  T Alon; I Hemo; A Itin; J Pe'er; J Stone; E Keshet
Journal:  Nat Med       Date:  1995-10       Impact factor: 53.440

View more
  22 in total

1.  RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism.

Authors:  Bing Ma; Charles S Dela Cruz; Dominik Hartl; Min-Jong Kang; Shervin Takyar; Robert J Homer; Chun Geun Lee; Jack A Elias
Journal:  Am J Respir Crit Care Med       Date:  2011-01-28       Impact factor: 21.405

2.  Benefits of pre-, pro- and Syn-biotics for lung angiogenesis in malnutritional rats exposed to intermittent hypoxia.

Authors:  Asma Ahmad; Charles L Cai; Dharmendra Kumar; Fayme Cai; Antoni D'Souza; Lawrence Fordjour; Taimur Ahmad; Gloria B Valencia; Jacob V Aranda; Kay D Beharry
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

3.  An endothelial TLR4-VEGFR2 pathway mediates lung protection against oxidant-induced injury.

Authors:  Seyedtaghi Takyar; Yi Zhang; Maria Haslip; Lei Jin; Peiying Shan; Xuchen Zhang; Patty J Lee
Journal:  FASEB J       Date:  2015-12-11       Impact factor: 5.191

4.  Subtyping Chronic Obstructive Pulmonary Disease Using Peripheral Blood Proteomics.

Authors:  Sara Zarei; Ali Mirtar; Jarrett D Morrow; Peter J Castaldi; Paula Belloni; Craig P Hersh
Journal:  Chronic Obstr Pulm Dis       Date:  2017-02-08

Review 5.  Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease.

Authors:  Chun Geun Lee; Bing Ma; Seyedtaghi Takyar; Farida Ahangari; Charles Delacruz; Chuan Hua He; Jack A Elias
Journal:  Proc Am Thorac Soc       Date:  2011-11

6.  Rapid remodeling of airway vascular architecture at birth.

Authors:  Amy Ni; Erin Lashnits; Li-Chin Yao; Peter Baluk; Donald M McDonald
Journal:  Dev Dyn       Date:  2010-09       Impact factor: 3.780

7.  Chronic intermittent hypoxia induces lung growth in adult mice.

Authors:  Christian Reinke; Shannon Bevans-Fonti; Dmitry N Grigoryev; Luciano F Drager; Allen C Myers; Robert A Wise; Alan R Schwartz; Wayne Mitzner; Vsevolod Y Polotsky
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-12-03       Impact factor: 5.464

8.  In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.

Authors:  James E Dahlman; Carmen Barnes; Omar Khan; Aude Thiriot; Siddharth Jhunjunwala; Taylor E Shaw; Yiping Xing; Hendrik B Sager; Gaurav Sahay; Lauren Speciner; Andrew Bader; Roman L Bogorad; Hao Yin; Tim Racie; Yizhou Dong; Shan Jiang; Danielle Seedorf; Apeksha Dave; Kamaljeet S Sandu; Matthew J Webber; Tatiana Novobrantseva; Vera M Ruda; Abigail K R Lytton-Jean; Christopher G Levins; Brian Kalish; Dayna K Mudge; Mario Perez; Ludmila Abezgauz; Partha Dutta; Lynelle Smith; Klaus Charisse; Mark W Kieran; Kevin Fitzgerald; Matthias Nahrendorf; Dganit Danino; Rubin M Tuder; Ulrich H von Andrian; Akin Akinc; Avi Schroeder; Dipak Panigrahy; Victor Kotelianski; Robert Langer; Daniel G Anderson
Journal:  Nat Nanotechnol       Date:  2014-05-11       Impact factor: 39.213

9.  TP53-dependent autophagy links the ATR-CHEK1 axis activation to proinflammatory VEGFA production in human bronchial epithelial cells exposed to fine particulate matter (PM2.5).

Authors:  Xiuduan Xu; Hongli Wang; Shasha Liu; Chen Xing; Yang Liu; Wei Zhou; Xiaoyan Yuan; Yongfu Ma; Meiru Hu; Yongliang Hu; Shuxian Zou; Ye Gu; Shuangqing Peng; Shengtao Yuan; Weiping Li; Yuanfang Ma; Lun Song
Journal:  Autophagy       Date:  2016-07-27       Impact factor: 16.016

Review 10.  Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Authors:  Nina A Mikirova; James A Jackson; Ron Hunninghake; Julian Kenyon; Kyle W H Chan; Cathy A Swindlehurst; Boris Minev; Amit N Patel; Michael P Murphy; Leonard Smith; Doru T Alexandrescu; Thomas E Ichim; Neil H Riordan
Journal:  J Transl Med       Date:  2009-12-15       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.